- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.12.25 | AB&B BIO-TECH-B (02627): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | - | HKEx | ||
| AB&B BIO-TECH Aktie jetzt für 0€ handeln | |||||
| 23.12.25 | AB&B BIO-TECH-B (02627): (1) POLL RESULTS OF THE SECOND EXTRAORDINARY GENERAL MEETING OF 2025 (2) APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND ... | 1 | HKEx | ||
| 08.12.25 | AB&B BIO-TECH-B (02627): VOLUNTARY ANNOUNCEMENT - COMMENCEMENT OF PHASE III CLINICAL TRIAL FOR LYOPHILIZED HUMAN RABIES VACCINE (HUMAN DIPLOID CELL) | 1 | HKEx | ||
| 04.12.25 | AB&B BIO-TECH-B (02627): FORM OF PROXY FOR THE SECOND EXTRAORDINARY GENERAL MEETING OF 2025 TO BE HELD ON TUESDAY, DECEMBER 23, 2025 AND ANY ADJOURNMENT ... | 1 | HKEx | ||
| 04.12.25 | AB&B BIO-TECH-B (02627): (1) APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR (2) RE-APPOINTMENT OF AUDITORS AND (3) NOTICE OF EGM | 4 | HKEx | ||
| 04.12.25 | AB&B BIO-TECH-B (02627): NOTICE OF THE SECOND EXTRAORDINARY GENERAL MEETING OF 2025 | - | HKEx | ||
| 04.12.25 | AB&B BIO-TECH-B (02627): (I) RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR; (II) NOMINATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR; AND (III) CHANGE ... | 1 | HKEx | ||
| 13.11.25 | AB&B BIO-TECH-B (02627): VOLUNTARY ANNOUNCEMENT - COMMENCEMENT OF PHASE I CLINICAL TRIAL FOR ADJUVANTED QUADRIVALENT SUBUNIT INFLUENZA VACCINE AND ADJUVANTED ... | 1 | HKEx | ||
| 15.10.25 | AB&B BIO-TECH-B (02627): INSIDE INFORMATION - APPLICATION FOR THE H SHARE FULL CIRCULATION BY THE COMPANY | - | HKEx | ||
| 29.09.25 | AB&B BIO-TECH-B (02627): NOTIFICATION LETTER TO NON-REGISTERED HOLDERS OF H SHARES AND REQUEST FORM - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE ... | - | HKEx | ||
| 29.09.25 | AB&B BIO-TECH-B (02627): NOTIFICATION LETTER TO REGISTERED H SHAREHOLDERS - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS | 1 | HKEx | ||
| 29.09.25 | AB&B BIO-TECH-B (02627): 2025 INTERIM REPORT | - | HKEx | ||
| 03.09.25 | AB&B BIO-TECH-B (02627): VOLUNTARY ANNOUNCEMENT - APPROVAL OF OUR APPLICATION FOR QUADRIVALENT SUBUNIT INFLUENZA VACCINE BY THE NMPA | 1 | HKEx | ||
| 28.08.25 | AB&B BIO-TECH-B (02627): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025 | 1 | HKEx | ||
| 15.08.25 | AB&B BIO-TECH-B (02627): DATE OF BOARD MEETING | - | HKEx | ||
| 13.08.25 | AB&B BIO-TECH-B (02627): VOLUNTARY ANNOUNCEMENT | 1 | HKEx | ||
| 08.08.25 | AB&B BIO-TECH-B (02627): ANNOUNCEMENT OF FINAL OFFER PRICE AND ALLOTMENT RESULTS | - | HKEx | ||
| 08.08.25 | AB&B BIO-TECH-B (02627): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 1 | HKEx | ||
| 08.08.25 | AB&B BIO-TECH-B (02627): TERMS OF REFERENCE - NOMINATION COMMITTEE | 1 | HKEx | ||
| 08.08.25 | AB&B BIO-TECH-B (02627): TERMS OF REFERENCE - REMUNERATION AND APPRAISAL COMMITTEE | 1 | HKEx |
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|
Das Unternehmen AB&B BIO-TECH CO LTD JS kann der Branche Biotechnologie zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu AB&B BIO-TECH CO LTD JS finden Sie auf Wallstreet Online.